Simulations Plus - רווח תפעולי EBITDA SLP

By leveraging cloud hosting and affiliate marketing, Simulations Plus, Inc. (SLP) is optimizing its operating expenses. The digitalization of preclinical testing reduces physical logistics, thereby increasing margins, while the M&A strategy expands its algorithmic stack. Actual EBITDA demonstrates the fundamental resilience of the business, with the 17.98 mark serving as a current indicator of the company's liquidity and cash flow management efficiency.

This indicator measures actual cash flow from operating activities before depreciation and taxes, allowing for a real-time assessment of the business's ability to generate cash. By analyzing the EBITDA cash volume, an investor can see how the integration of AI into biosimulations for pharmaceuticals converts into operating profit, confirming the high fundamental stability of Simulations Plus, Inc. (SLP).